Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024
GlobeNewswire
*Bagsværd, Denmark, 2 May 2024 - financial report for the period 1 January 2024 to 31 March 2024*
· Operating profit..